Nafabeltan out, but push for homegrown COVID-19 drug continues
Mar 18, 2021
The competition to develop the country’s second COVID-19 treatment continues among South Korea’s major pharmaceutical companies after Chong Kun Dang Pharmaceutical recently dropped out. South Korea’...